Rwandamuriye F, Wang T, Zhang H, Elaskalani O, Kuster J, Ye X
Oncoimmunology. 2024; 13(1):2395067.
PMID: 39188754
PMC: 11346538.
DOI: 10.1080/2162402X.2024.2395067.
AbuBakar U, Amrani L, Kamarulzaman F, Karsani S, Hassandarvish P, Khairat J
Viruses. 2023; 15(4).
PMID: 37112812
PMC: 10142937.
DOI: 10.3390/v15040833.
Reyes M, Leff S, Gentili M, Hacohen N, Blainey P
Sci Adv. 2023; 9(8):eade5090.
PMID: 36827376
PMC: 9956118.
DOI: 10.1126/sciadv.ade5090.
Sun N, Zhang R, Song G, Cai Q, Aliyari S, Nielsen-Saines K
J Med Virol. 2023; 95(2):e28451.
PMID: 36594413
PMC: 9975044.
DOI: 10.1002/jmv.28451.
Mishra G, Jha A, Ahad A, Sen K, Sen A, Podder S
Cell Mol Life Sci. 2022; 79(8):429.
PMID: 35849243
PMC: 9293861.
DOI: 10.1007/s00018-022-04424-w.
Synergistic Effects of Toll-Like Receptor 1/2 and Toll-Like Receptor 3 Signaling Triggering Interleukin 27 Gene Expression in Chikungunya Virus-Infected Macrophages.
Valdes-Lopez J, Fernandez G, Urcuqui-Inchima S
Front Cell Dev Biol. 2022; 10:812110.
PMID: 35223841
PMC: 8863767.
DOI: 10.3389/fcell.2022.812110.
Rotavirus Interactions With Host Intestinal Epithelial Cells.
Amimo J, Raev S, Chepngeno J, Mainga A, Guo Y, Saif L
Front Immunol. 2022; 12:793841.
PMID: 35003114
PMC: 8727603.
DOI: 10.3389/fimmu.2021.793841.
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
Anfray C, Mainini F, Digifico E, Maeda A, Sironi M, Erreni M
J Immunother Cancer. 2021; 9(9).
PMID: 34531246
PMC: 8449972.
DOI: 10.1136/jitc-2021-002408.
Stimulus-specific responses in innate immunity: Multilayered regulatory circuits.
Luecke S, Sheu K, Hoffmann A
Immunity. 2021; 54(9):1915-1932.
PMID: 34525335
PMC: 8452151.
DOI: 10.1016/j.immuni.2021.08.018.
Innate control of adaptive immunity and adaptive instruction of innate immunity: bi-directional flow of information.
McDaniel M, Meibers H, Pasare C
Curr Opin Immunol. 2021; 73:25-33.
PMID: 34425435
PMC: 8648974.
DOI: 10.1016/j.coi.2021.07.013.
The Transcription Factor SUB1 Is a Master Regulator of the Macrophage TLR Response in Atherosclerosis.
Huang R, Hu Z, Chen X, Cao Y, Li H, Zhang H
Adv Sci (Weinh). 2021; 8(19):e2004162.
PMID: 34378353
PMC: 8498911.
DOI: 10.1002/advs.202004162.
A synthetic pathogen mimetic molecule induces a highly amplified synergistic immune response activation of multiple signaling pathways.
Nihesh N, Manna S, Studnitzer B, Shen J, Esser-Kahn A
Chem Sci. 2021; 12(19):6646-6651.
PMID: 34040739
PMC: 8132936.
DOI: 10.1039/d1sc00964h.
Engineering Supramolecular Organizing Centers for Optogenetic Control of Innate Immune Responses.
Tan P, He L, Zhou Y
Adv Biol (Weinh). 2021; 5(5):e2000147.
PMID: 34028210
PMC: 8144545.
DOI: 10.1002/adbi.202000147.
Towards complete and error-free genome assemblies of all vertebrate species.
Rhie A, McCarthy S, Fedrigo O, Damas J, Formenti G, Koren S
Nature. 2021; 592(7856):737-746.
PMID: 33911273
PMC: 8081667.
DOI: 10.1038/s41586-021-03451-0.
Babaodan controls excessive immune responses and may represent a cytokine-targeted agent suitable for COVID-19 treatment.
Qian J, Xu H, Lv D, Liu W, Chen E, Zhou Y
Biomed Pharmacother. 2021; 139:111586.
PMID: 33866132
PMC: 8030745.
DOI: 10.1016/j.biopha.2021.111586.
Single-tube genotyping for small insertion/deletion mutations: simultaneous identification of wild type, mutant and heterozygous alleles.
Lin B, Sun J, Fraser I
Biol Methods Protoc. 2021; 5(1):bpaa007.
PMID: 33782652
PMC: 7334877.
DOI: 10.1093/biomethods/bpaa007.
Living in a Hostile World: Inflammation, New Drug Development, and Coronavirus.
Dobson G, Biros E, Letson H, Morris J
Front Immunol. 2021; 11:610131.
PMID: 33552070
PMC: 7862725.
DOI: 10.3389/fimmu.2020.610131.
Immunological design of commensal communities to treat intestinal infection and inflammation.
Brown R, Larkinson M, Clarke T
PLoS Pathog. 2021; 17(1):e1009191.
PMID: 33465156
PMC: 7846104.
DOI: 10.1371/journal.ppat.1009191.
Pairwise Stimulations of Pathogen-Sensing Pathways Predict Immune Responses to Multi-adjuvant Combinations.
Pandey S, Gruenbaum A, Kanashova T, Mertins P, Cluzel P, Chevrier N
Cell Syst. 2020; 11(5):495-508.e10.
PMID: 33113356
PMC: 7677225.
DOI: 10.1016/j.cels.2020.10.001.
Exploring the Role of TRIP-Brs in Human Breast Cancer: An Investigation of Expression, Clinicopathological Significance, and Prognosis.
Mongre R, Mishra C, Jung S, Lee B, Quynh N, Anh N
Mol Ther Oncolytics. 2020; 19:105-126.
PMID: 33102693
PMC: 7554327.
DOI: 10.1016/j.omto.2020.09.003.